Key result
Levosimendan evaluation yields no specific efficacy results versus milrinone for adult pulmonary hypertension.
Why the study?
Levosimendan is a potential alternative to milrinone for patients with pulmonary hypertension, motivating an evaluation of their comparative efficacy.
Population
Adults with pulmonary hypertension
Comparison
Levosimendan vs milrinone
Design
Systematic review and meta-analysis
Answers are grounded in this paper and cite their sources.
Positions levosimendan as a viable inotropic alternative in pulmonary hypertension; extends prior heart failure data.
Levosimendan, is a potential alternative to Milrinone for patients with pulmonary hypertension. The aim of this meta-analysis is to evaluate the efficacy of Levosimendan versus Milrinone in adults with pulmonary hypertension.
No takes yet. Share an insight, caveat, or question.
Rizwan et al. (2026) studied this question. Levosimendan is being evaluated as a potential alternative to milrinone for adults with pulmonary hypertension, but the abstract provides no specific efficacy results.
Synapse has enriched 10 related papers. Consider them for comparative context: